Jazz Pharmaceuticals plc

Brandywine Global Investment Management, LLC JAZZ

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

36,197

Value ($000)

6,153

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	6,153	0.0%	36,197	12/31/2025
2025 Q2	8/12/2025	28,795	0.2%	271,340	6/30/2025
2025 Q1	5/13/2025	48,577	0.4%	391,276	3/31/2025
2024 Q4	2/12/2025	47,010	0.3%	381,730	12/31/2024
2024 Q3	11/12/2024	42,538	0.3%	383,120	9/30/2024
2024 Q2	8/14/2024	40,980	0.3%	383,957	6/30/2024
2024 Q1	5/13/2024	52,570	0.4%	436,557	3/31/2024
2023 Q4	2/9/2024	47,234	0.4%	384,020	12/31/2023
2023 Q3	11/13/2023	46,233	0.4%	357,174	9/30/2023
2023 Q2	8/11/2023	46,532	0.4%	375,350	6/30/2023
2023 Q1	5/12/2023	56,822	0.5%	388,317	3/31/2023
2022 Q4	2/10/2023	54,412	0.4%	341,548	12/31/2022
2022 Q3	11/14/2022	43,867	0.4%	329,111	9/30/2022
2022 Q2	8/11/2022	52,262	0.5%	334,989	6/30/2022
2022 Q1	5/13/2022	52,946	0.4%	340,115	3/31/2022
2021 Q4	2/11/2022	44,598	0.3%	350,059	12/31/2021
2021 Q3	11/12/2021	44,387	0.3%	340,889	9/30/2021
2021 Q2	8/13/2021	35,754	0.3%	201,270	6/30/2021
2021 Q1	5/13/2021	43,422	0.3%	264,175	3/31/2021
2020 Q4	2/10/2021	35,833	0.3%	217,101	12/31/2020
2020 Q3	11/12/2020	40,564	0.4%	284,476	9/30/2020
2020 Q2	8/14/2020	31,776	0.3%	287,977	6/30/2020
2020 Q1	5/15/2020	23,921	0.3%	239,832	3/31/2020
2019 Q4	2/14/2020	53,865	0.4%	362,896	12/31/2019